Filed: 5/14/2025ACC: 0001104659-25-048519
📋 What this filing means
BELLEVUE GROUP AG filed this quarterly 13F‑HR report disclosing 148 equity positions with a total reported market value of $4.46B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
148
Positions
$4.46B
Total AUM (reported)
99.95M
Total Shares
Allocation by class
COM$3.48B77.9%
SPONSORED ADR$346.74M7.8%
COM NEW$301.39M6.8%
SHS$121.16M2.7%
COMMON STOCK$42.63M1.0%
CL A$38.31M0.9%
ADS$36.25M0.8%
Portfolio Concentration
Top 3$790.46M17.7%
4–10$1.38B30.9%
11–25$1.07B24.1%
Rest$1.22B27.3%
Top 3 weight
17.7%
Top 10 weight
48.6%
Voting Authority Distribution
Total shares with voting rights: 99.95M
Sole
Full voting authority
99.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other148
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings148
Rows:
ARGENX SE
DFNDShares578.87K
TypeSH
Market value$342.62M
7.68%
Sole
578.87K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
DFNDShares7.85M
TypeSH
Market value$236.93M
5.31%
Sole
7.85M
Shared
0.00
None
0.00
STRYKER CORPORATION
DFNDShares566.60K
TypeSH
Market value$210.92M
4.73%
Sole
566.60K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
DFNDShares425.75K
TypeSH
Market value$210.86M
4.72%
Sole
425.75K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
DFNDShares768.15K
TypeSH
Market value$207.42M
4.65%
Sole
768.15K
Shared
0.00
None
0.00
ABBOTT LABS
DFNDShares1.56M
TypeSH
Market value$206.42M
4.63%
Sole
1.56M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
DFNDShares1.82M
TypeSH
Market value$201.29M
4.51%
Sole
1.82M
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
DFNDShares413.07K
TypeSH
Market value$200.27M
4.49%
Sole
413.07K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
DFNDShares1.95M
TypeSH
Market value$196.82M
4.41%
Sole
1.95M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
DFNDShares4.37M
TypeSH
Market value$154.68M
3.47%
Sole
4.37M
Shared
0.00
None
0.00
INCYTE CORP
DFNDShares2.09M
TypeSH
Market value$126.66M
2.84%
Sole
2.09M
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
DFNDShares3.52M
TypeSH
Market value$102.99M
2.31%
Sole
3.52M
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
DFNDShares164.74K
TypeSH
Market value$86.28M
1.93%
Sole
164.74K
Shared
0.00
None
0.00
MEDTRONIC PLC
DFNDShares938.36K
TypeSH
Market value$84.32M
1.89%
Sole
938.36K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
DFNDShares2.51M
TypeSH
Market value$80.60M
1.81%
Sole
2.51M
Shared
0.00
None
0.00
BECTON DICKINSON & CO
DFNDShares344.31K
TypeSH
Market value$78.87M
1.77%
Sole
344.31K
Shared
0.00
None
0.00
DEXCOM INC
DFNDShares1.06M
TypeSH
Market value$72.67M
1.63%
Sole
1.06M
Shared
0.00
None
0.00
INSULET CORP
DFNDShares271.29K
TypeSH
Market value$71.24M
1.60%
Sole
271.29K
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
DFNDShares971.97K
TypeSH
Market value$70.45M
1.58%
Sole
971.97K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
DFNDShares3.07M
TypeSH
Market value$55.75M
1.25%
Sole
3.07M
Shared
0.00
None
0.00
PENUMBRA INC
DFNDShares204.52K
TypeSH
Market value$54.69M
1.23%
Sole
204.52K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
DFNDShares1.25M
TypeSH
Market value$50.63M
1.13%
Sole
1.25M
Shared
0.00
None
0.00
BIOHAVEN LTD
DFNDShares2.04M
TypeSH
Market value$49.06M
1.10%
Sole
2.04M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
DFNDShares2.40M
TypeSH
Market value$46.79M
1.05%
Sole
2.40M
Shared
0.00
None
0.00
MODERNA INC
DFNDShares1.52M
TypeSH
Market value$43.04M
0.96%
Sole
1.52M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARGENX SEDFND | SPONSORED ADR | 578.87K | SH | $342.62M 7.68% | 578.87K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCDFND | COM | 7.85M | SH | $236.93M 5.31% | 7.85M | 0.00 | 0.00 |
STRYKER CORPORATIONDFND | COM | 566.60K | SH | $210.92M 4.73% | 566.60K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCDFND | COM NEW | 425.75K | SH | $210.86M 4.72% | 425.75K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCDFND | COM | 768.15K | SH | $207.42M 4.65% | 768.15K | 0.00 | 0.00 |
ABBOTT LABSDFND | COM | 1.56M | SH | $206.42M 4.63% | 1.56M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCDFND | COM | 1.82M | SH | $201.29M 4.51% | 1.82M | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCDFND | COM | 413.07K | SH | $200.27M 4.49% | 413.07K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPDFND | COM | 1.95M | SH | $196.82M 4.41% | 1.95M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 4.37M | SH | $154.68M 3.47% | 4.37M | 0.00 | 0.00 |
INCYTE CORPDFND | COM | 2.09M | SH | $126.66M 2.84% | 2.09M | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCDFND | COM | 3.52M | SH | $102.99M 2.31% | 3.52M | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCDFND | COM | 164.74K | SH | $86.28M 1.93% | 164.74K | 0.00 | 0.00 |
MEDTRONIC PLCDFND | SHS | 938.36K | SH | $84.32M 1.89% | 938.36K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPDFND | COM | 2.51M | SH | $80.60M 1.81% | 2.51M | 0.00 | 0.00 |
BECTON DICKINSON & CODFND | COM | 344.31K | SH | $78.87M 1.77% | 344.31K | 0.00 | 0.00 |
DEXCOM INCDFND | COM | 1.06M | SH | $72.67M 1.63% | 1.06M | 0.00 | 0.00 |
INSULET CORPDFND | COM | 271.29K | SH | $71.24M 1.60% | 271.29K | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPDFND | COM | 971.97K | SH | $70.45M 1.58% | 971.97K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWDFND | COM NEW | 3.07M | SH | $55.75M 1.25% | 3.07M | 0.00 | 0.00 |
PENUMBRA INCDFND | COM | 204.52K | SH | $54.69M 1.23% | 204.52K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCDFND | COM | 1.25M | SH | $50.63M 1.13% | 1.25M | 0.00 | 0.00 |
BIOHAVEN LTDDFND | COM | 2.04M | SH | $49.06M 1.10% | 2.04M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCDFND | COM | 2.40M | SH | $46.79M 1.05% | 2.40M | 0.00 | 0.00 |
MODERNA INCDFND | COM | 1.52M | SH | $43.04M 0.96% | 1.52M | 0.00 | 0.00 |
Page 1 of 6
…